glp-1 drug medications get at the heart of addiction: study – WashU Medicine GLP-1 Drugs and the Physiology

Market analysts anticipate eight or more novel GLP-1-based approvals for chronic weight management over the next four years, as the drug class extends from its metabolic origins into a broader platform for addressing diseases with underlying inflammatory and cardiometabolic components

Clinical studies have shown that patients using GLP-1 therapies often achieve greater weight loss than through diet and exercise alone

Focus more on total dietary fiber intake, however, below are some of the best soluble fiber sources

Journal of Periodontology

Elafibranor and liraglutide improve differentially liver health and metabolism in a mouse model of non-alcoholic steatohepatitis

Future studies may explore the potential of GLP-1RAs in tumor therapy